Skip to main navigation
Skip to search
Skip to main content
Mayo Clinic Home
Home
Profiles
Departments/Divisions
Grants
Research output
Prizes
Search by expertise, name or affiliation
Genomic and epigenomic analysis of high-risk prostate cancer reveals changes in hydroxymethylation and TET1
For the PEARL consortium
Urology
Research output
:
Contribution to journal
›
Article
›
peer-review
19
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Genomic and epigenomic analysis of high-risk prostate cancer reveals changes in hydroxymethylation and TET1'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Medicine & Life Sciences
Epigenomics
100%
Prostatic Neoplasms
90%
DNA
47%
Neoplasms
36%
Cell Polarity
35%
Exome
34%
Cytosine
34%
Protein Transport
31%
Point Mutation
27%
Prostate
23%
Genome
19%
Neoplasm Metastasis
17%
Gene Expression
17%
Messenger RNA
16%
Mutation
16%
Survival
15%
Genes
11%
Therapeutics
4%